Fragasso Financial Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
AIM
FWIA
DLA
Fragasso Financial Advisors's BMY Position: Q2 2026 in Review
Fragasso Financial Advisors increased its Bristol-Myers Squibb (BMY) stake by 26% in Q2 2026, buying an estimated $54.5K and bringing the position to 4,605 shares worth $265K. The position accounts for 0.01% of the portfolio, ranked #306.
Fragasso Financial Advisors first reported a position in BMY in Q1 2024 and has held it in 4 quarters since. 954 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Fragasso Financial Advisors held 4,605 shares of Bristol-Myers Squibb worth $265K as of Q2 2026.
- Fragasso Financial Advisors bought 949 Bristol-Myers Squibb shares in Q2 2026, an estimated $54.5K.
- Bristol-Myers Squibb made up 0.01% of Fragasso Financial Advisors's portfolio in Q2 2026, its #306 holding.
- Fragasso Financial Advisors first reported a position in Bristol-Myers Squibb in Q1 2024 and has held it in 4 quarters since.
- 954 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Fragasso Financial Advisors's 13F filing for Q2 2026, filed 9 Jul 2026.